Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96
To evaluate the safety and effectiveness of autologous gp96 treatment of liver cancer and Pancreatic Adenocarcinoma
Liver Cancer|Pancreatic Adenocarcinoma
BIOLOGICAL: autologous gp96 vaccination
blood count, blood count within 3 days before first vaccination, baseline|blood count, blood count within 3 days after the second injection, within 3 days after the second injection|blood count, blood count within 3 days after the 6th injection, within 3 days after the 6th injection|blood chemistries, blood chemistries (including serum glutamic oxaloacetic transaminase/ aspartate aminotransferase \[AST\], serum alanine amino transferase \[ALT\], serum alkaline phosphatase, serum total bilirubin, serum blood urea nitrogen\[BUN\], serum creatinine, serum total protein and serum albumin) within 3 days before first vaccination, baseline|blood chemistries, blood chemistries (including serum glutamic oxaloacetic transaminase/ aspartate aminotransferase \[AST\], serum alanine amino transferase \[ALT\], serum alkaline phosphatase, serum total bilirubin, serum blood urea nitrogen\[BUN\], serum creatinine, serum total protein and serum albumin) within 3 days after the second injection, within 3 days after the second injection|blood chemistries, blood chemistries (including serum glutamic oxaloacetic transaminase/ aspartate aminotransferase \[AST\], serum alanine amino transferase \[ALT\], serum alkaline phosphatase, serum total bilirubin, serum blood urea nitrogen\[BUN\], serum creatinine, serum total protein and serum albumin) within 3 days after the 6th injection, within 3 days after the 6th injection|electrocardiogram, electrocardiogram test within 3 days before first vaccination, baseline|electrocardiogram, electrocardiogram test within 3 days after the second injection, within 3 days after the second injection|electrocardiogram, electrocardiogram test within 3 days after the 6th injection, within 3 days after the 6th injection
Disease-free survival, up to 3 years|overall survive, up to 3 years|changes in antigen specific T cells, tumor antigen specific T cells was determined by IFN-Î³ Enzyme-linked immunosorbent spot using the autologous tumor cell lysis as the antigen., baseline and within 3 days before the 6th injection
Change from baseline in subpopulation of CD8+ T cells at the end of vaccination, analysis of the expression of CCR7 \& CD45RA of CD8+ T cells by FCM within 3 days before first vaccination and within 3 days after the 6th vaccination., within 3 days before the first vaccination, within 3 days after the 6th vaccination
To evaluate the safety and effectiveness of autologous gp96 treatment of liver cancer and Pancreatic Adenocarcinoma